Parallel Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Parallel Advisors's ADPT Position: Q2 2026 in Review
Parallel Advisors held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 10,078 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.
Parallel Advisors first reported a position in ADPT in Q1 2021 and has held it in 22 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Parallel Advisors held 10,078 shares of Adaptive Biotechnologies worth $216K as of Q2 2026.
- Parallel Advisors left its Adaptive Biotechnologies share count unchanged in Q2 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1220 holding.
- Parallel Advisors first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 22 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.